Corvus Pharmaceuticals, Inc.·4

Sep 13, 4:56 PM ET

Grais Linda 4

4 · Corvus Pharmaceuticals, Inc. · Filed Sep 13, 2021

Insider Transaction Report

Form 4
Period: 2021-09-09
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-09-09+15,00015,000 total
    Exercise: $2.60Exp: 2031-09-09Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the first anniversary of the grant date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4